PTC Therapeutics | Beneficio Operativo



Operating Profit Cambio Fecha
Acadia Pharmaceuticals USD 32.37M 13.08M 2025-06
Alnylam Pharmaceuticals USD -16199000 34.28M 2025-06
Amgen USD 1.29B 1.02B 2025-03
Biogen USD 851.8M 540.6M 2025-06
BioMarin Pharmaceutical USD 276.89M 52.99M 2025-06
Cytokinetics USD -155631000 16.59M 2025-03
Daiichi Sankyo JPY 96.71B 13.1B 2025-06
Gilead Sciences USD 2.24B 215M 2025-03
Incyte USD 310.82M 105.66M 2025-06
Ionis Pharmaceuticals USD 139.84M 285.84M 2025-06
Ironwood Pharmaceuticals USD 33.22M 7.58M 2024-12
Novartis USD 4.86B 201M 2025-06
Pfizer USD 2.6B 1.06B 2025-06
PTC Therapeutics USD 970.22M 1.03B 2025-03
Roche Holding CHF 4.39B 1.04B 2024-12
Sarepta Therapeutics USD 115.58M 415.96M 2025-06
TG Therapeutics USD 34.84M 26.22M 2025-06
Ultragenyx Pharmaceutical USD -193567000 50.63M 2025-06
Vertex Pharmaceuticals USD 1.15B 123.1M 2025-06
Xencor USD -43183000 47.23M 2025-03


PTC Therapeutics Beneficio Operativo - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Aug 2025.